Prevalence and incidence of acute and chronic comorbidity in patients with squamous cell carcinoma of the head and neck
BACKGROUND: Limited data exist on the burden of comorbidity among patients with squamous cell head and neck cancer (SCCHN) before and during cancer treatment. METHODS: The precancer prevalence and incidence rates of 8 comorbid conditions were estimted among a population-based cohort of 1499 patients with SCCHN in the Netherlands